The occurrence of many skin diseases is actually caused by an imbalance in the skin's microbiota. Our team has a history of over 15 years of researching the relationship between skin probiotics and diseases, and has published more than 30 related papers in international journals. Therefore, the founding mission of our team is to achieve the therapeutic treatment of skin diseases through the interaction mechanisms of microorganisms. Currently, the team possesses more than 50 types of skin probiotics, each with its own unique cultivation method. In addition, we have also invented 12 types of probio-carbons that can treat 8 different skin diseases. Over the past few years, our team's research on utilizing skin probiotic fermentation to combat pathogens has also received three STTR, one R01, and multiple R21 awards from the U.S. National Institutes of Health (NIH), and we have also transferred part of our technology to a U.S. cosmetics company. This fully demonstrates the market potential of Pmicrobiome. We believe that the aforementioned related products can not only create new opportunities in Taiwan's medical aesthetics skincare, skin disease treatment, and testing markets, but we also expect to develop internationally and occupy an important position in the relevant markets.
(The content above was translated by AI.)